Caseware UK (AP4) 2025.0.111 2025.0.111 2026-01-312026-01-31falseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false5false52025-02-01No description of principal activitytrue 14590049 2025-02-01 2026-01-31 14590049 2024-02-01 2025-01-31 14590049 2026-01-31 14590049 2025-01-31 14590049 c:Director4 2025-02-01 2026-01-31 14590049 d:CurrentFinancialInstruments 2026-01-31 14590049 d:CurrentFinancialInstruments 2025-01-31 14590049 d:CurrentFinancialInstruments d:WithinOneYear 2026-01-31 14590049 d:CurrentFinancialInstruments d:WithinOneYear 2025-01-31 14590049 d:RetainedEarningsAccumulatedLosses 2026-01-31 14590049 d:RetainedEarningsAccumulatedLosses 2025-01-31 14590049 c:FRS102 2025-02-01 2026-01-31 14590049 c:AuditExempt-NoAccountantsReport 2025-02-01 2026-01-31 14590049 c:FullAccounts 2025-02-01 2026-01-31 14590049 c:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 14590049 2 2025-02-01 2026-01-31 14590049 e:PoundSterling 2025-02-01 2026-01-31 iso4217:GBP xbrli:pure
Registered number: 14590049







UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 JANUARY 2026


SEL COMMUNITY PHARMACY FED LIMITED







































 


SEL COMMUNITY PHARMACY FED LIMITED
REGISTERED NUMBER:14590049



STATEMENT OF FINANCIAL POSITION
AS AT 31 JANUARY 2026

2026
2025
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
-
1,543

Cash at bank and in hand
  
1,452,921
1,280,181

  
1,452,921
1,281,724

Creditors: amounts falling due within one year
 5 
(1,449,375)
(1,283,433)

Net current assets/(liabilities)
  
 
 
3,546
 
 
(1,709)

Total assets less current liabilities
  
3,546
(1,709)

  

Net assets/(liabilities)
  
3,546
(1,709)


Capital and reserves
  

Profit and loss account
  
3,546
(1,709)

  
3,546
(1,709)


Page 1

 


SEL COMMUNITY PHARMACY FED LIMITED
REGISTERED NUMBER:14590049


    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 JANUARY 2026

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 28 October 2026.




S A Patel
Director

The notes on pages 3 to 4 form part of these financial statements.

Page 2

 


SEL COMMUNITY PHARMACY FED LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026

1.


General information

SEL Community Pharmacy Fed Limited is a private company, limited by guarantee, registered in England and Wales, company registration number 14590049. The registered office and principal place of business is 1st Floor Office, 89 Station Road, West Wickham, Kent, United Kingdom, BR4 0PX. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. 

 
2.3

Government grants

Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income.

Grants of a revenue nature are recognised in the Statement of income and retained earnings in the same period as the related expenditure.

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.5

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of financial position. The assets of the plan are held separately from the Company in independently administered funds.

Page 3

 


SEL COMMUNITY PHARMACY FED LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026

2.Accounting policies (continued)

 
2.6

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.


 
2.7

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.


3.


Employees

The average monthly number of employees, including directors, during the year was 5 (2025 - 5).


4.


Debtors

2026
2025
£
£


Trade debtors
-
1,536

Other debtors
-
7

-
1,543



5.


Creditors: Amounts falling due within one year

2026
2025
£
£

Trade creditors
-
2,700

Corporation tax
3,959
3,669

Other taxation and social security
2,324
13,886

Other creditors
1,439,792
1,260,328

Accruals and deferred income
3,300
2,850

1,449,375
1,283,433


 
Page 4